Oct 18 2024 |
FDA Issues Exemptions from November 27, 2024 Compliance Deadline for Updated DSCSA Requirements |
Polsinelli PC |
Oct 18 2024 |
Survey on Carbon-Based Nanomaterials and Analytical Methods Closes November 1, 2024 |
Bergeson & Campbell, P.C. |
Oct 18 2024 |
Trending in Telehealth: October 7 – 14, 2024 |
McDermott Will & Emery |
Oct 18 2024 |
FDA’s Voluntary Sodium Reduction Goals: Key Takeaways from Recent Webinar |
Keller and Heckman LLP |
Oct 18 2024 |
Teva Pharmaceuticals Agrees to Pay $450 Million to Resolve FCA Claims |
ArentFox Schiff LLP |
Oct 17 2024 |
California Enacts Law to Standardize Date Labels |
Keller and Heckman LLP |
Oct 17 2024 |
TSCA and the Food (and Food Packaging) Exemptions |
Keller and Heckman LLP |
Oct 17 2024 |
This Week in 340B: October 8 – 14, 2024 |
McDermott Will & Emery |
Oct 17 2024 |
New DEA Rule Expected to Extend Controlled Substance Telemedicine Prescribing Flexibilities Through 2025 |
Foley & Lardner LLP |
Oct 17 2024 |
Federal Appeals Court Says Certain THC-O Products Are Legal Contrary to DEA Interpretation |
Bradley Arant Boult Cummings LLP |
Oct 17 2024 |
Insulin Overpricing Lawsuits: What Patients and Families Need to Know |
Oberheiden P.C. |
Oct 16 2024 |
September 2024 Bounty Hunter Plaintiff Claims |
Keller and Heckman LLP |
Oct 16 2024 |
Big AI Appetites May Cause Heartburn |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 16 2024 |
PAGA Reform May Curb Appetite for Litigation |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 16 2024 |
California Legislature Eighty-Six’s “Junk Fee Ban,” But Relief May Be Temporary |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 16 2024 |
California’s FAST Act to Go, But NLRB Delivers a New Joint-Employer Rule |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 16 2024 |
Court Dismisses Challenge to Strengthening Organic Enforcement Rule |
Keller and Heckman LLP |
Oct 16 2024 |
Federal Appeals Court Upholds “Zero-Tolerance” Cannabis Policy Under North Carolina Law |
Bradley Arant Boult Cummings LLP |
Oct 16 2024 |
Recent Federal Developments for October 2024 |
Bergeson & Campbell, P.C. |
Oct 15 2024 |
Johnson & Johnson Case Sparks Concerns Over Future Excessive Health Fee Litigation |
Jackson Lewis P.C. |
Oct 15 2024 |
New Liquor License Laws Aim to Assist Applicants in New York |
Greenberg Traurig, LLP |
Oct 15 2024 |
European Parliament Fast Tracks Deforestation Regulation Entry into Force Amendment |
Squire Patton Boggs (US) LLP |
Oct 15 2024 |
FSIS Extends Comment Period on Proposed Salmonella Rule |
Keller and Heckman LLP |
Oct 15 2024 |
New Pittsburgh Ordinance Expands Medical Cannabis Drug Testing Protections |
Norris McLaughlin P.A. |
Oct 14 2024 |
Medicare Coverage: CMS Finalizes New Pathway for Breakthrough Devices |
Foley & Lardner LLP |
Oct 14 2024 |
Does Kamala Harris Support Marijuana Legalization? Squaring Words with Actions in an Evolving Political Environment |
Bradley Arant Boult Cummings LLP |
Oct 14 2024 |
HHS Final Rule Targets Suspicious Billing Practices for Medical Equipment (CMS-1799-F) |
Nelson Mullins |
Oct 12 2024 |
EFSA Publishes Reports under NAMs4NANO Project |
Bergeson & Campbell, P.C. |
Oct 11 2024 |
Pending DEA Extension on Prescription of Controlled Substances via Telemedicine |
McDermott Will & Emery |
Oct 11 2024 |
Weight Loss Drug Shortages Will End Soon |
McDermott Will & Emery |
Oct 11 2024 |
Tirzepatide Shortage Resolved |
McDermott Will & Emery |
Oct 11 2024 |
McDermott+ Check-Up (Special Regulatory Edition): October 11, 2024 |
McDermott Will & Emery |
Oct 10 2024 |
Why Can’t Weed Be Friends? How Marijuana and Hemp Businesses Can Both Win, and Win America |
Bradley Arant Boult Cummings LLP |
Oct 10 2024 |
Federal Court Enters Consent Decree Against Rizo Lopez Foods Linked to Listeria Outbreak |
Keller and Heckman LLP |
Oct 10 2024 |
Federal Circuit Finds Evidence of Infringement, Willfulness, and Damages Insufficient as a Matter of Law |
Barnes & Thornburg LLP |